Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation

Platelets

Volumn 14, Issue 7-8, 2003, Pages 429-435

  Kempfert, Jörg ^a   Behrends, Sönke ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; MAGNESIUM ION; MANGANESE; NITRIC OXIDE;

ARTICLE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR TRANSPORT; KINETICS; PRIORITY JOURNAL; PROTEIN TRANSPORT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; WESTERN BLOTTING;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; BLOTTING, WESTERN; CELL MEMBRANE; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME ACTIVATORS; GUANYLATE CYCLASE; HUMANS; INDAZOLES; KINETICS; MAGNESIUM; MANGANESE; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 0347302937     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953710032000141752     Document Type: Article

References (27)

1. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-62.
2. Mehta J L, Chen L Y, Kone B C, Mehta P, Turner, P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med 1995; 125: 370-7.
3. Freedman J E, Loscalzo J, Barnard M R, Alpert C, Keaney J F, Michelson A D. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-6.
4. Peire M A, Puig-Parellada P. Oxygen-free radicals and nitric oxide are involved in the thrombus growth produced by iontophoresis of ADP. Pharmacol Res 1998; 38: 353-6.
5. Hobbs A J. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 1997; 18: 484-91.
6. Lucas K A, Pitari G M, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik K P, Waldman S A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414.
7. Guthmann F, Mayer B, Koesling D, Kukovetz W R, Böhme E. Characterization of soluble platelet guanylyl cyclase with peptide antibodies. Naunyn Schmiedebergs Arch Pharmacol 1992; 346: 537-41.
8. Tesmer J J, Sunahara R K, Johnson R A, Gosselin G, Gilman A G. Sprang S R. Two-metal-Ion catalysis in adenylyl cyclase. Science 1999; 285: 756-60.
9. Serfass L, Carr H S, Aschenbrenner L M, Burstyn J N. Calcium ion downregulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism. Arch Biochem Biophys 2001; 387: 47-56.
10. Hwang D L, Yen C F, Nadler J L. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab 1993; 76: 549-53.
11. Takaya J, Higashino H, Miyazaki R, Kobayashi, Y. Effects of insulin and insulin-like growth factor-1 on intracellular magnesium of platelets. Exp Mol Pathol 1998; 65: 104-9.
12. 2+ in essential hypertension. Am J Physiol 1998; 275, R574-9.
13. Nadler J L, Malayan S, Luong H, Shaw S, Natarajan R D, Rude R K. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992; 15: 835-41.
14. Shechter M, Merz C N, Rude R K, Paul Labrador M J, Meisel S R, Shah P K, Kaul S. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J 2000; 140: 212-8.
15. Kots A Y, Grafov M A, Khropov Y V, Betin V L, Belushkina N N, Busygina O G, Yazykova M Y, Ovchinnikov I V, Kulikov A S, Makhova N N, Medvedeva N A, Bulargina T V, Severina I S. Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols. Br J Pharmacol 2000; 129: 1163-77.
16. Wu C C, Ko F N, Kuo S C, Lee F Y, Teng C M. YC-1, a novel activator of platelet guanylate cyclase. Br J Pharmacol 1995; 116: 1973-8.
17. Ko F N, Wu C C, Kuo S C, Lee F Y, Teng C. YC-1, a novel activator of platelet guanylate cyclase. Blood 1994; 84: 4226-33.
18. Stamler J S, Vaughan D E, Loscalzo J. Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin. Circ Res 1989; 65: 796-804.
19. Salas E, Moro M A, Askew S, Hodson H F, Butler A R, Radomski M W, Moncada S. Comparative pharmacology of analogues of 5-nitroso-N-acetyl-DL- penicillamine on human platelets. Br J Pharmacol 1994; 112: 1071-6.
20. Friebe A, Mullershausen F, Smolenski A, Walter U, Schultz G, Koesling D. YC1 potentiates nitric oxide-and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol 1998; 54: 962-7.
21. Schultz G, Böhme E. Guanylate cyclase. GTP pyrophosphatelyase (cyclizing). E.C.4.6.1.2. Methods Enzymatic Anal 1984; 4: 379-89.
22. Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, Muller H, Kronich P. Kugler P, Walter U, Schnitzer JE, Schmidt HH. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol 2002; 4: 307-11.
23. Kerwin J F, Lancaster J R, Feldman P F. Nitric oxide: a new paradigm for second messengers. J Med Chem 1995; 38: 4343-62.
24. Bellamy T C, Wood J, Goodwin D A, Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci USA 2000; 97: 2928-33.
25. Nighorn A, Byrnes K A, Morton D B. Identification and characterization of a novel beta subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide. J Biol Chem 1999; 274: 2525-31.
26. 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J Biol Chem 2001; 276: 30737-43.
27. Zimmermann G, Zhou D, Taussig R. Mutations uncover a role for two magnesium ions in the catalytic mechanism of adenylyl cyclase. J Biol Chem 1998; 273: 19650-5.